In Hodgkin lymphoma or multiple myeloma, FoxO1 displays a tumor‐suppressive role as it is frequently deleted or mediates therapy‐induced cytotoxicity, respectively [6, 7]. This evidence concerns the gene FOXO1 and AL amyloidosis.